Phibro Animal Health Corp (PAHC): Net Income
$99.72M
Year ended 2026-06-30
+45.2%
3-year compound annual growth
+12.9%
5-year compound annual growth
+1.9%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $99.72M | +106.6% | 2026-08-26, From 2025-07-01 |
| 2025-06-30 | $48.26M | n/m | 2026-08-26, From 2024-07-01 |
| 2024-06-30 | $2.42M | -92.6% | 2026-08-26, From 2023-07-01 |
| 2023-06-30 | $32.61M | -33.7% | 2025-08-27, From 2022-07-01 |
| 2022-06-30 | $49.17M | -9.6% | 2024-08-28, From 2021-07-01 |
| 2021-06-30 | $54.38M | +62.1% | 2023-08-30, From 2020-07-01 |
| 2020-06-30 | $33.55M | -38.7% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $54.71M | -15.7% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $64.88M | +0.4% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $64.61M | -21.9% | 2019-08-27, From 2016-07-01 |
| 2016-06-30 | $82.73M | +37.2% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $60.28M | n/m | 2017-08-30, From 2014-07-01 |
| 2014-06-30 | -$3.13M | n/m | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | $24.89M | +256.8% | 2015-09-10, From 2012-07-01 |
| 2012-06-30 | $6.98M | n/a | 2014-09-18, From 2011-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $99.72M | +106.6% |
| Alkermes plc. (ALKS) | 2025-12-31 | $241.66M | -34.2% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $682.64M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $210.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $190.30M | -11.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $391.00M | +72.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$713.41M | n/m |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $770.95M | -10.2% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$288.28M | n/m |
Compare PAHC, ALKS, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗